NASDAQ:CPIX - Cumberland Pharmaceuticals Stock Price, Forecast & News

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) posted its quarterly earnings data on Tuesday, November, 12th. The specialty pharmaceutical company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.11 by $0.10. The specialty pharmaceutical company had revenue of $10.37 million for the quarter, compared to analysts' expectations of $12.65 million. Cumberland Pharmaceuticals had a positive return on equity of 6.76% and a negative net margin of 10.13%. View Cumberland Pharmaceuticals' Earnings History.

Cumberland Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Cumberland Pharmaceuticals.

1 equities research analysts have issued 12 month price objectives for Cumberland Pharmaceuticals' stock. Their forecasts range from $9.75 to $9.75. On average, they expect Cumberland Pharmaceuticals' stock price to reach $9.75 in the next year. This suggests a possible upside of 95.8% from the stock's current price. View Analyst Price Targets for Cumberland Pharmaceuticals.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cumberland Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cumberland Pharmaceuticals.

News articles about CPIX stock have trended positive on Tuesday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cumberland Pharmaceuticals earned a daily sentiment score of 2.2 on InfoTrie's scale. They also assigned news stories about the specialty pharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Cumberland Pharmaceuticals.

Cumberland Pharmaceuticals saw a decrease in short interest in December. As of December 31st, there was short interest totalling 82,400 shares, a decrease of 12.7% from the December 15th total of 94,400 shares. Based on an average daily volume of 14,900 shares, the days-to-cover ratio is currently 5.5 days. Currently, 0.9% of the shares of the stock are sold short. View Cumberland Pharmaceuticals' Current Options Chain.

Some companies that are related to Cumberland Pharmaceuticals include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR) and Zogenix (ZGNX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include NovaBay Pharmaceuticals (NBY), MacroGenics (MGNX), Amicus Therapeutics (FOLD), Protalix Biotherapeutics (PLX), AcelRx Pharmaceuticals (ACRX), Akari Therapeutics (AKTX), Allena Pharmaceuticals (ALNA), Biocept (BIOC), Calithera Biosciences (CALA) and Catalyst Biosciences (CBIO).

Shares of CPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CPIX stock can currently be purchased for approximately $4.98.

Cumberland Pharmaceuticals has a market capitalization of $75.60 million and generates $40.74 million in revenue each year. The specialty pharmaceutical company earns $-6,960,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis. Cumberland Pharmaceuticals employs 80 workers across the globe.View Additional Information About Cumberland Pharmaceuticals.

The official website for Cumberland Pharmaceuticals is http://www.cumberlandpharma.com/.

Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The specialty pharmaceutical company can be reached via phone at 615-255-0068 or via email at [email protected]